Table 1.

Description of patient cohort

	Astrocytoma (n = 23)	Oligodendroglioma (n = 14)	Overall (n = 37)
Age at diagnosis
Median [interquartile range (IQR)]	31.0 [27.5, 38.5]	37.0 [32.25, 44]	33.0 [28.0, 39.0]
Sex
Female	11 (47.8%)	6 (42.9%)	17 (45.9%)
Male	12 (52.2%)	8 (57.1%)	20 (54.1%)
TMZ cycles
Median [IQR]	12.0 [11.75, 15.25]	21.5 [12.0, 24.0]	12.0 [12, 22.5]
Grade at recurrence
II	6 (26.1%)	3 (21.4%)	9 (24.3%)
III	6 (26.1%)	11 (78.6%)	17 (45.9%)
IV	11 (47.8%)		11 (29.7%)
HM status at recurrence
HM	9 (39.1%)	6 (42.9%)	15 (40.5%)
Mixed	2 (8.7%)	1 (7.1%)	3 (8.1%)
nonHM	12 (52.2%)	7 (50.0%)	19 (51.4%)